Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources
- PMID: 22655033
- PMCID: PMC3360037
- DOI: 10.1371/journal.pone.0037024
Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources
Abstract
Several Acinetobacter strains have utility for biotechnology applications, yet some are opportunistic pathogens. We compared strains of seven Acinetobacter species (baumannii, Ab; calcoaceticus, Ac; guillouiae, Ag; haemolyticus, Ah; lwoffii, Al; junii, Aj; and venetianus, Av-RAG-1) for their potential virulence attributes, including proliferation in mammalian cell conditions, haemolytic/cytolytic activity, ability to elicit inflammatory signals, and antibiotic susceptibility. Only Ah grew at 10(2) and 10(4) bacteria/well in mammalian cell culture medium at 37°C. However, co-culture with colonic epithelial cells (HT29) improved growth of all bacterial strains, except Av-RAG-1. Cytotoxicity of Ab and Ah toward HT29 was at least double that of other test bacteria. These effects included bacterial adherence, loss of metabolism, substrate detachment, and cytolysis. Only Ab and Ah exhibited resistance to killing by macrophage-like J774A.1 cells. Haemolytic activity of Ah and Av-RAG-1 was strong, but undetectable for other strains. When killed with an antibiotic, Ab, Ah, Aj and Av-RAG-1 induced 3 to 9-fold elevated HT29 interleukin (IL)-8 levels. However, none of the strains altered levels of J774A.1 pro-inflammatory cytokines (IL-1β, IL-6 and tumor necrosis factor-α). Antibiotic susceptibility profiling showed that Ab, Ag and Aj were viable at low concentrations of some antibiotics. All strains were positive for virulence factor genes ompA and epsA, and negative for mutations in gyrA and parC genes that convey fluoroquinolone resistance. The data demonstrate that Av-RAG-1, Ag and Al lack some potentially harmful characteristics compared to other Acinetobacter strains tested, but the biotechnology candidate Av-RAG-1 should be scrutinized further prior to widespread use.
Conflict of interest statement
Figures
References
-
- de Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, et al. Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii? PLoS ONE. 2010;5:e10732. doi: 10.1371/journal.pone.0010732. - DOI - PMC - PubMed
-
- Euzéby JP. List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet. Int J Syst Bacteriol. 1997;47:590–592. - PubMed
-
- Dijkshoorn L, Nemec A. The Diversity of the Genus Acinetobacter. In: Gerischer U, editor. Acinetobacter molecular microbiology. Horizon Scientific Press; 2008.
-
- Luckarift HR, Sizemore SR, Farrington KE, Fulmer PA, Biffinger JC, et al. 2011. Biodegradation of medium chain hydrocarbons by Acinetobacter venetianus 2AW immobilized to hair-based adsorbent mats. Biotechnology Progress. Available: http://www.ncbi.nlm.nih.gov/pubmed/21948333. Accessed 28 October 2011. - PubMed
-
- Abdel-El-Haleem D. Acinetobacter: environmental and biotechnological applications. African Journal of Biotechnology. 2003;2:71–74.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
